Role of Interferon-Gamma Release Assay for the Diagnosis and Clinical Follow up in Ocular Tuberculosis

References

• Gupta A, Sharma A, Bansal R, Sharma K. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):7–13. doi:10.3109/09273948.2014.967358.
   PubMed Web of Science ®Google Scholar
• Gupta V, Gupta A, Rao NA. Intraocular tuberculosis--an update. Surv Ophthalmol. 2007;52(6):561–587. doi:10.1016/j.survophthal.2007.08.015.
   PubMed Web of Science ®Google Scholar
• Trad S, Saadoun D, Errera MH, et al. Tuberculose oculaire. Rev Med Interne. 2018 Sep;39(9):755–764. doi: 10.1016/j.revmed.2018.05.003.
   PubMedGoogle Scholar
• Kee AR, Gonzalez-Lopez JJ, Al-Hity A, et al. Anti-tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis. Surv Ophthalmol. 2016;61(5):628–653. doi: 10.1016/j.survophthal.2016.03.001.
   PubMed Web of Science ®Google Scholar
• Biswas J, Madhavan HN, Gopal L, Badrinath SS. Intraocular tuberculosis. Clinicopathologic study of five cases. Retina. 1995;15(6):461–468. doi: 10.1097/00006982-199515060-00001.
   PubMed Web of Science ®Google Scholar
• Ang M, Wong W, Ngan CC, Chee S-P. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye (Lond). 2012;26(5):658–665. doi:10.1038/eye.2012.1.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Grant R, Gupta B, et al. What does IGRA testing add to the diagnosis of ocular tuberculosis? A Bayesian latent class analysis. BMC Ophthalmol. Published 2017 Dec 8;17(1):245. doi: 10.1186/s12886-017-0597-x.
   PubMedGoogle Scholar
• Urzua CA, Liberman P, Abuauad S, et al. Evaluation of the accuracy of T-SPOT.TB for the diagnosis of ocular tuberculosis in a BCG-vaccinated, non-endemic population. Ocul Immunol Inflamm. 2017;25(4):455–459. doi: 10.3109/09273948.2015.1135965.
   PubMed Web of Science ®Google Scholar
• Pai M, Zwerling A, Menzies D. Systematic review: T-cell–based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177–184. doi:10.7326/0003-4819-149-3-200808050-00241.
   PubMed Web of Science ®Google Scholar
• Ang M, Wong WL, Li X, Chee SP. Interferon γ release assay for the diagnosis of uveitis associated with tuberculosis: a Bayesian evaluation in the absence of a gold standard. Br J Ophthalmol. 2013;97(8):1062–1067. doi:10.1136/bjophthalmol-2012-302199.
   PubMed Web of Science ®Google Scholar
• Hamade IH, Tabbara KF. Complications of presumed ocular tuberculosis. Acta Ophthalmol. 2010 Dec;88(8):905–909. doi: 10.1111/j.1755-3768.2009.01579.x.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191‐2194. doi: 10.1001/jama.2013.281053.
   Web of Science ®Google Scholar
• Saúde MD. Conselho Nacional de Saúde, Brasilia, Brasil. Brasília: Diário Oficial da União, resolution no. 466. http://conselho.saude.gov.br/resolucoes/2012/reso466.pdf. Published December 12, 2012. Accessed August 20, 2018.
   Google Scholar
• Agrawal R, Gunasekeran DV, Raje D, et al. Global variations and challenges with Tubercular Uveitis in the collaborative Ocular Tuberculosis Study. Invest Ophthalmol Vis Sci. 2018;59(10):4162–4171. doi: 10.1167/iovs.18-24102.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Agarwal A, Jabs DA, et al. Standardization of nomenclature for ocular tuberculosis – results of collaborative Ocular Tuberculosis Study (COTS) workshop. Ocul Immunol Inflamm. 2019;10:1–11. doi: 10.1080/09273948.2019.1653933.
   Google Scholar
• Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017 Jan 15;64(2):111–115. doi: 10.1093/cid/ciw778.
   PubMedGoogle Scholar
• Screen for TB with confidence. https://www.quantiferon.com/wp-content/uploads/2017/04/PROM-9282-002_1101652_BRO_QFT-Plus.pdf. Published April, 2016. Accessed January 4, 2020.
   Google Scholar
• Petruccioli E, Chiacchio T, Vanini V, et al. Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection. Sci Rep. 2018;8(1):15626. doi: 10.1038/s41598-018-33825-w.
   PubMedGoogle Scholar
• Pai M, Joshi R, Dogra S, et al. T-cell assay conver sions and reversions among household contacts of tuber culosis pati ents in rural India. Int J Tuberc Lung Dis. Jan 2009;13(1):84–92.
   PubMed Web of Science ®Google Scholar
• Ministério da Saúde (MS). Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Manual de Recomendações para o Controle da Tuberculose no Brasil. 2ª ed. Brasília: MS; 2019. https://sbpt.org.br/portal/wp-content/uploads/2019/06/manual_recomendacoes_tb_2ed_atualizada_8maio19.pdf. Accessed: January 4, 2020.
   Google Scholar
• Testi I, Agrawal R, Mahajan S, et al. Tubercular uveitis: nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1. Ocul Immunol Inflamm. 2019;25:1–9. doi: 10.1080/09273948.2019.1646774.
   Google Scholar
• Gineys R, Bodaghi B, Carcelain G, et al. QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation. Am J Ophthalmol. 2011;152(3):433–440.e1. doi: 10.1016/j.ajo.2011.02.006.
   PubMed Web of Science ®Google Scholar
• Sudharshan S, Ganesh SK, Balu G, et al. Utility of QuantiFERON®-TB Gold test in diagnosis and management of suspected tubercular uveitis in India. Int Ophthalmol. 2012;32(3):217–223. doi: 10.1007/s10792-012-9554-0.
   PubMedGoogle Scholar
• Llorenç V, González-Martin J, Keller J, et al. Indirect supportive evidence for diagnosis of tuberculosis-related uveitis: from the tuberculin skin test to the new interferon gamma release assays. Acta Ophthalmol. 2013;91(2):e99–e107. doi: 10.1111/j.1755-3768.2012.02564.x.
   PubMed Web of Science ®Google Scholar
• Albini TA, Karakousis PC, Rao NA. Interferon-gamma release assays in the diagnosis of tuberculous uveitis. Am J Ophthalmol. 2008;146(4):486–488. doi:10.1016/j.ajo.2008.06.021.
   PubMed Web of Science ®Google Scholar
• Ang M, Htoon HM, Chee S-P. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology. 2009;116(7):1391–1396. doi:10.1016/j.ophtha.2009.02.005.
   PubMed Web of Science ®Google Scholar
• Cordero-Coma M, Calleja S, Torres HE, et al. The value of an immune response to mycobacterium tuberculosis in patients with chronic posterior uveitis revisited: utility of the new IGRAs. Eye. 2010;24(1):36–43. doi: 10.1038/eye.2009.51.
   PubMed Web of Science ®Google Scholar
• Trad S, Bodaghi B, Saadoun D. Update on immunological test (Quantiferon-TB Gold) contribution in the management of tuberculosis-related ocular inflammation. Ocul Immunol Inflamm. 2018;26(8):1192–1199. doi:10.1080/09273948.2017.1332232.
   PubMed Web of Science ®Google Scholar
• Ang M, Nguyen HV, Kiew SY, Chen S, Chee SP, Finkelstein E. Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis. Br J Ophthalmol. 2015;99(7):984–989. doi:10.1136/bjophthalmol-2014-306285.
   PubMed Web of Science ®Google Scholar
• Castro AT, Mendes M, Freitas S, Roxo PC. Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a period of 10 years. Rev Port Pneumol (2006). May-Jun 2015 ;21(3):144–150. doi:10.1016/j.rppnen.2014.08.004.
   PubMedGoogle Scholar
• Ang M, Kiew SY, Wong WL, Chee S-P. Discordance of two interferon-γ release assays and tuberculin skin test in patients with uveitis. Br J Ophthalmol. 2014;98(12):1649–1653. doi:10.1136/bjophthalmol-2014-305229.
   PubMed Web of Science ®Google Scholar
• Farhat M, Greenaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10(11):1192–1204.
   PubMed Web of Science ®Google Scholar
• Babu K, Bhat SS, Philips M, Subbakrishna DK. Review of results of QuantiFERON TB gold test in presumed ocular tuberculosis in a South Indian patient population. Ocul Immunol Inflamm. 2016 Oct;24(5):498–502. doi: 10.3109/09273948.2015.1010094.
   PubMed Web of Science ®Google Scholar
• La Distia Nora R, van Velthoven MEJ, Ten Dam-van Loon NH, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON–TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014 Apr;157(4):754–761. doi: 10.1016/j.ajo.2013.11.013.
   PubMed Web of Science ®Google Scholar
• Pai M, Joshi R, Dogra S, et al. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol. 2006;1(1):7. doi: 10.1186/1745-6673-1-7.
   PubMedGoogle Scholar
• Zhang BY, Yu ZM, Yang QL, et al. Serial anti-tuberculous immune responses during the follow-up of patients with tuberculous pleurisy. Medicine (Baltimore). 2020;99(2):e18367. doi: 10.1097/MD.0000000000018367.
   PubMed Web of Science ®Google Scholar
• Hang NTL, Matsushita I, Shimbo T, et al. Association between tuberculosis recurrence and interferon-γ response during treatment. J Infect. 2014;69(6):616–626. doi: 10.1016/j.jinf.2014.06.007.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Gonzalez-Lopez JJ, Nobre-Cardoso J, et al. Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence. Br J Ophthalmol. 2016;100(3):348–355. doi: 10.1136/bjophthalmol-2014-306474.
   PubMed Web of Science ®Google Scholar
• Clifford V, He Y, Zufferey C, Connell T, Curtis N. Interferon gamma release assays for monitoring the response to treatment for tuberculosis: a systematic review. Tuberculosis (Edinb). 2015 Dec;95(6):639–650. doi: 10.1016/j.tube.2015.07.002.
   PubMed Web of Science ®Google Scholar
• Behr MA, Edelstein PH, Ramakrishnan L. Revisiting the timetable of tuberculosis. BMJ. 2018 Aug 23;362:k2738. doi: 10.1136/bmj.k2738.
   PubMedGoogle Scholar
• Pourakbari B, Mamishi S, Benvari S, et al. Can interferon-γ release assays be useful for monitoring the response to anti-tuberculosis treatment?: a systematic review and meta-analysis. Arch Immunol Ther Exp (Warsz). 2020 Feb 3;68(1):4. doi: 10.1007/s00005-020-00568-4.
   PubMed Web of Science ®Google Scholar